Latest Medical statistics Stories
Quorum Review IRB, the industry leader in central IRB services, announces Mitchell E.
PROFICIENCY™ Conference to Address Endpoint Strategies for Safety and Efficacy Data in Clinical Research Tokyo, Japan (PRWEB) September 10, 2013 ERT,
A new study published in the open access journal PLOS Biology suggests that the scientific literature could be compromised by substantial bias in the reporting of animal studies, and may be giving a misleading picture of the chances that potential treatments could work in humans.
Clinical trials of drug treatments for neurological diseases such as Alzheimer's and Parkinson's often fail because the animal studies that preceded them were poorly designed or biased in their interpretation.
- totally perplexed and mixed up.